These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 24719095)
1. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice. Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Tolerance in S426A/S430A x Piscura MK; Sepulveda DE; Maulik M; Guindon J; Henderson-Redmond AN; Morgan DJ J Pharmacol Exp Ther; 2023 Apr; 385(1):17-34. PubMed ID: 36669876 [TBL] [Abstract][Full Text] [Related]
3. Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice. Nealon CM; Henderson-Redmond AN; Hale DE; Morgan DJ Neuropharmacology; 2019 Apr; 148():151-159. PubMed ID: 30629988 [TBL] [Abstract][Full Text] [Related]
4. Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ Henderson-Redmond AN; Sepulveda DE; Ferguson EL; Kline AM; Piscura MK; Morgan DJ Psychopharmacology (Berl); 2022 May; 239(5):1289-1309. PubMed ID: 34165606 [TBL] [Abstract][Full Text] [Related]
5. Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic. Marcus DJ; Zee ML; Davis BJ; Haskins CP; Andrews MJ; Amin R; Henderson-Redmond AN; Mackie K; Czyzyk TA; Morgan DJ PLoS One; 2016; 11(8):e0160462. PubMed ID: 27501235 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test. LaFleur RA; Wilson RP; Morgan DJ; Henderson-Redmond AN Neuroreport; 2018 Apr; 29(6):447-452. PubMed ID: 29461336 [TBL] [Abstract][Full Text] [Related]
7. c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner. Henderson-Redmond AN; Nealon CM; Davis BJ; Yuill MB; Sepulveda DE; Blanton HL; Piscura MK; Zee ML; Haskins CP; Marcus DJ; Mackie K; Guindon J; Morgan DJ Neuropharmacology; 2020 Mar; 164():107847. PubMed ID: 31758947 [TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain. Henderson-Redmond AN; Crawford LC; Sepulveda DE; Hale DE; Lesperance JJ; Morgan DJ Front Mol Biosci; 2021; 8():684115. PubMed ID: 34250019 [TBL] [Abstract][Full Text] [Related]
9. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors. Smith PA; Selley DE; Sim-Selley LJ; Welch SP Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035 [TBL] [Abstract][Full Text] [Related]
10. Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption. Marcus DJ; Henderson-Redmond AN; Gonek M; Zee ML; Farnsworth JC; Amin RA; Andrews MJ; Davis BJ; Mackie K; Morgan DJ PLoS One; 2017; 12(4):e0174826. PubMed ID: 28426670 [TBL] [Abstract][Full Text] [Related]
11. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. Jin W; Brown S; Roche JP; Hsieh C; Celver JP; Kovoor A; Chavkin C; Mackie K J Neurosci; 1999 May; 19(10):3773-80. PubMed ID: 10234009 [TBL] [Abstract][Full Text] [Related]
12. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner. Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443 [TBL] [Abstract][Full Text] [Related]
13. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227 [TBL] [Abstract][Full Text] [Related]
14. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Daigle TL; Kearn CS; Mackie K Neuropharmacology; 2008 Jan; 54(1):36-44. PubMed ID: 17681354 [TBL] [Abstract][Full Text] [Related]
15. Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ Ford BM; Cabanlong CV; Tai S; Franks LN; Penthala NR; Crooks PA; Prather PL; Fantegrossi WE J Pharmacol Exp Ther; 2019 May; 369(2):259-269. PubMed ID: 30833484 [TBL] [Abstract][Full Text] [Related]
16. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387 [TBL] [Abstract][Full Text] [Related]
17. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions. Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286 [TBL] [Abstract][Full Text] [Related]
18. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820 [TBL] [Abstract][Full Text] [Related]